10 results for "clinical trial"

New Pill Cuts Triglycerides 38% in Early Human Trial
🧘 Health & Wellness

New Pill Cuts Triglycerides 38% in Early Human Trial

Scientists have developed the first oral medication that safely lowers dangerous blood fats by targeting the liver, without harming the body's protective cholesterol systems. After years of roadblocks, this breakthrough could help millions at risk for heart disease and stroke.

New Sepsis Drug Shows Promise in 180-Patient China Trial
🧘 Health & Wellness

New Sepsis Drug Shows Promise in 180-Patient China Trial

A groundbreaking sepsis treatment successfully completed Phase II trials with 180 patients in China, offering hope for millions facing one of the world's deadliest hospital conditions. The carbohydrate-based drug could reach the market within years, potentially saving countless lives from a condition that currently has no specific cure.

Alzheimer's Drug Shows Promise for Sickle Cell Patients
🧘 Health & Wellness

Alzheimer's Drug Shows Promise for Sickle Cell Patients

A safe, affordable medication already used for Alzheimer's disease could become a game-changer for people with sickle cell anemia, especially in resource-limited areas. Early clinical trials show memantine reduces hospitalizations and painful episodes while improving quality of life.

New Sepsis Drug Shows Promise in 180-Patient Trial
🧘 Health & Wellness

New Sepsis Drug Shows Promise in 180-Patient Trial

A breakthrough drug candidate successfully reduced sepsis symptoms in a 180-patient trial, offering hope for a condition that kills millions worldwide. Researchers at Griffith University could bring the first specific anti-sepsis therapy to market within years.

Smoking Drug Cuts Cannabis Use 33% in Men With Addiction
🧘 Health & Wellness

Smoking Drug Cuts Cannabis Use 33% in Men With Addiction

A medication already used to help smokers quit might offer the first real treatment for cannabis addiction, reducing use by a third in men during clinical trials. Scientists are now working to understand why the drug didn't help women in the same way.

Kentucky Cancer Center Treats 1st US Patient with New Therapy
🧘 Health & Wellness

Kentucky Cancer Center Treats 1st US Patient with New Therapy

A Kentucky cancer center just treated the first American patient with a powerful new lung cancer drug that could help people who've run out of options. The experimental therapy grabs cancer cells twice as tight as current treatments, giving hope to patients battling one of the deadliest cancers.

New Lung Cancer Treatment Restores Immune System Function
🧘 Health & Wellness

New Lung Cancer Treatment Restores Immune System Function

A breakthrough immunotherapy is helping lung cancer patients rebuild their weakened immune systems, offering hope beyond traditional chemotherapy. In trials, patients who responded lived up to 21 months, marking a potential shift in how doctors treat the disease.

New Lupus Drug Shows Major Results in Self-Inject Trial
🧘 Health & Wellness

New Lupus Drug Shows Major Results in Self-Inject Trial

A breakthrough lupus treatment that patients can give themselves at home just showed remarkable results in a major trial, with 56% of participants experiencing significant improvement. The self-administered version could transform treatment for millions living with this challenging autoimmune disease.

Harvard Researchers Bridge Healthcare Gaps Using Insurance Data to Help More Patients
🧘 Health & Wellness

Harvard Researchers Bridge Healthcare Gaps Using Insurance Data to Help More Patients

Harvard Medical School researchers have developed an innovative method using real-world insurance data to extend life-saving medical knowledge to patients traditionally left out of clinical trials. Their groundbreaking approach is already helping more people access effective treatments and informing global health guidelines.

UK Research Team Doses 817 Vaccine Trial Volunteers in Just Six Weeks
🧘 Health & Wellness

UK Research Team Doses 817 Vaccine Trial Volunteers in Just Six Weeks

In an impressive display of clinical excellence, hVIVO's UK team successfully recruited and dosed over 800 healthy volunteers for a major vaccine trial in just over six weeks. The achievement showcases how dedicated healthcare professionals and efficient coordination can advance medical research at remarkable speed.